Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

A modified protocol with vincristine, topotecan, and cyclophosphamide for recurrent/progressive ewing sarcoma family tumors.

Kebudi R, Cakir FB, Gorgun O, Agaoglu FY, Darendeliler E.

Pediatr Hematol Oncol. 2013 Apr;30(3):170-7. doi: 10.3109/08880018.2013.767868.

PMID:
23484903
2.

Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution.

Farhat R, Raad R, Khoury NJ, Feghaly J, Eid T, Muwakkit S, Abboud M, El-Solh H, Saab R.

J Pediatr Hematol Oncol. 2013 Jul;35(5):356-60. doi: 10.1097/MPH.0b013e318270a343.

PMID:
23042020
3.

Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors.

Hunold A, Weddeling N, Paulussen M, Ranft A, Liebscher C, Jürgens H.

Pediatr Blood Cancer. 2006 Nov;47(6):795-800.

PMID:
16411206
4.

Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.

Mascarenhas L, Felgenhauer JL, Bond MC, Villaluna D, Femino JD, Laack NN, Ranganathan S, Meyer J, Womer RB, Gorlick R, Krailo MD, Marina N.

Pediatr Blood Cancer. 2016 Mar;63(3):493-8. doi: 10.1002/pbc.25837. Epub 2015 Nov 18.

PMID:
26579879
5.

Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study.

Walterhouse DO, Lyden ER, Breitfeld PP, Qualman SJ, Wharam MD, Meyer WH.

J Clin Oncol. 2004 Apr 15;22(8):1398-403. Epub 2004 Mar 8. Erratum in: J Clin Oncol. 2004 Aug 1;22(15):3205.

6.

Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.

Saylors RL 3rd, Stine KC, Sullivan J, Kepner JL, Wall DA, Bernstein ML, Harris MB, Hayashi R, Vietti TJ; Pediatric Oncology Group.

J Clin Oncol. 2001 Aug 1;19(15):3463-9.

PMID:
11481351
7.

A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors.

Yoon JH, Kwon MM, Park HJ, Park SY, Lim KY, Joo J, Park BK.

BMC Cancer. 2014 Aug 28;14:622. doi: 10.1186/1471-2407-14-622.

8.

Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.

Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW.

Cancer. 2002 Sep 15;95(6):1354-65.

9.

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.

Kushner BH, Meyers PA, Gerald WL, Healey JH, La Quaglia MP, Boland P, Wollner N, Casper ES, Aledo A, Heller G, et al.

J Clin Oncol. 1995 Nov;13(11):2796-804.

PMID:
7595741
10.

Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.

Czyzewski EA, Goldman S, Mundt AJ, Nachman J, Rubin C, Hallahan DE.

Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):569-77.

PMID:
10348286
11.

VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.

El Weshi A, Memon M, Raja M, Bazarbashi S, Rahal M, El Foudeh M, Pai C, Allam A, El Hassan I, Ezzat A.

Am J Clin Oncol. 2004 Oct;27(5):529-34.

PMID:
15596925
12.

Response of children with stage IV soft tissue sarcoma to topotecan and carboplatin: a phase II window trial of the cooperative soft tissue sarcoma group.

Bochennek K, Dantonello T, Koscielniak E, Claviez A, Dirksen U, Sauerbrey A, Beilken A, Klingebiel T.

Klin Padiatr. 2013 Nov;225(6):309-14. doi: 10.1055/s-0033-1341489. Epub 2013 Aug 14.

PMID:
23946091
13.

Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.

Felgenhauer J, Hawkins D, Pendergrass T, Lindsley K, Conrad EU 3rd, Miser JS.

Med Pediatr Oncol. 2000 Jan;34(1):29-38.

PMID:
10611582
14.

Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).

Bernbeck B, Bahci S, Meisel R, Troeger A, Schönberger S, Laws HJ, Kramm C, Wessalowski R, Koscielniak E, Dilloo D, Göbel U.

Klin Padiatr. 2007 Nov-Dec;219(6):318-22.

PMID:
18050041
15.

[Chemotherapy in patients with refractory Ewing sarcoma].

Raciborska A, Bilska K, Drabko K, Rogowska E, Chaber R, Pogorzała M, Wyrobek E, Połczyńska K, Rodriguez-Galindo C, Woźniak W.

Med Wieku Rozwoj. 2013 Apr-Jun;17(2):117-25. Polish.

16.

Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?

Al-Faris N, Al Harbi T, Goia C, Pappo A, Doyle J, Gassas A.

Pediatr Blood Cancer. 2007 Aug;49(2):190-5.

PMID:
17262797
17.

Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group.

Bernstein ML, Devidas M, Lafreniere D, Souid AK, Meyers PA, Gebhardt M, Stine K, Nicholas R, Perlman EJ, Dubowy R, Wainer IW, Dickman PS, Link MP, Goorin A, Grier HE; Pediatric Oncology Group; Children's Cancer Group Phase II Study 9457; Children's Oncology Group.

J Clin Oncol. 2006 Jan 1;24(1):152-9.

18.

Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma.

Raciborska A, Bilska K, Drabko K, Chaber R, Pogorzala M, Wyrobek E, Polczyńska K, Rogowska E, Rodriguez-Galindo C, Wozniak W.

Pediatr Blood Cancer. 2013 Oct;60(10):1621-5. doi: 10.1002/pbc.24621. Epub 2013 Jun 15.

PMID:
23776128
19.

Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.

Arndt CA, Stoner JA, Hawkins DS, Rodeberg DA, Hayes-Jordan AA, Paidas CN, Parham DM, Teot LA, Wharam MD, Breneman JC, Donaldson SS, Anderson JR, Meyer WH.

J Clin Oncol. 2009 Nov 1;27(31):5182-8. doi: 10.1200/JCO.2009.22.3768. Epub 2009 Sep 21.

20.

Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.

Kinsella TJ, Glaubiger D, Diesseroth A, Makuch R, Waller B, Pizzo P, Glatstein E.

Int J Radiat Oncol Biol Phys. 1983 Dec;9(12):1955-60.

PMID:
9463099
Items per page

Supplemental Content

Write to the Help Desk